Price$0.27+0.01 (+3.52%)
01:30 PM07:45 PM
News · 26 weeks63+67%
2026-04-192026-10-11
Mix3090d
- SEC Filings13(43%)
- Insider9(30%)
- Other6(20%)
- Offering2(7%)
Latest news
25 items- SECSEC Form 6-K filed by NewGenIvf Group Limited6-K - NewGenIvf Group Ltd (0001981662) (Filer)
- SECSEC Form 6-K filed by NewGenIvf Group Limited6-K - NewGenIvf Group Ltd (0001981662) (Filer)
- INSIDERSEC Form 4 filed by NewGenIvf Group Limited4 - NewGenIvf Group Ltd (0001981662) (Issuer)
- INSIDERSEC Form 4 filed by NewGenIvf Group Limited4 - NewGenIvf Group Ltd (0001981662) (Issuer)
- SECSEC Form 6-K filed by NewGenIvf Group Limited6-K - NewGenIvf Group Ltd (0001981662) (Filer)
- SECSEC Form 6-K filed by NewGenIvf Group Limited6-K - NewGenIvf Group Ltd (0001981662) (Filer)
- PRNewGen Announces Closing of $1.25 Million Public OfferingBANGKOK, Oct. 01, 2026 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) (the "Company"), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced the closing of its previously announced public offering made on a reasonable best efforts basis with gross proceeds to the Company of approximately $1.25 million, before deducting placement agent fees and other offering expenses payable by the Company. The offering consisted of an aggregate of 17,857,143 Class A Ordinary Shares or pre-funded warrants to purchase Clas
- SECSEC Form 424B4 filed by NewGenIvf Group Limited424B4 - NewGenIvf Group Ltd (0001981662) (Filer)
- SECSEC Form EFFECT filed by NewGenIvf Group LimitedEFFECT - NewGenIvf Group Ltd (0001981662) (Filer)
- PRNewGen Announces Pricing of $1.25 Million Public OfferingBANGKOK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) (the "Company"), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced the pricing of a public offering made on a reasonable best efforts basis with gross proceeds to the Company expected to be approximately $1.25 million, before deducting placement agent fees and other offering expenses payable by the Company. The offering consists of 17,857,143 Ordinary Shares or Pre-Funded Warrants in lieu thereof. The public offering price per Comm
- SECAmendment: SEC Form F-1/A filed by NewGenIvf Group LimitedF-1/A - NewGenIvf Group Ltd (0001981662) (Filer)
- INSIDERSEC Form 3 filed by new insider Lau Tsz Hin Vincent3 - NewGenIvf Group Ltd (0001981662) (Issuer)
- INSIDERSEC Form 3 filed by new insider Lam Chun Tung Patrick3 - NewGenIvf Group Ltd (0001981662) (Issuer)
- INSIDERDirector Cheung Kong Yiu bought $4,163,334 worth of Class A Ordinary Shares (3,722,223 units at $1.12) (SEC Form 4)4 - NewGenIvf Group Ltd (0001981662) (Issuer)
- INSIDERSEC Form 3 filed by new insider Cheung Kong Yiu3 - NewGenIvf Group Ltd (0001981662) (Issuer)
- SECAmendment: SEC Form F-1/A filed by NewGenIvf Group LimitedF-1/A - NewGenIvf Group Ltd (0001981662) (Filer)
- SECSEC Form F-1 filed by NewGenIvf Group LimitedF-1 - NewGenIvf Group Ltd (0001981662) (Filer)
- INSIDERSEC Form 3 filed by new insider Lee Sze Mun3 - NewGenIvf Group Ltd (0001981662) (Issuer)
- SECSEC Form 6-K filed by NewGenIvf Group Limited6-K - NewGenIvf Group Ltd (0001981662) (Filer)
- INSIDERSEC Form 4 filed by Chairman & CEO Siu Wing Fung Alfred4 - NewGenIvf Group Ltd (0001981662) (Issuer)
- INSIDERSEC Form 4 filed by Chief Marketing Officer Fong Hei Yue Tina4 - NewGenIvf Group Ltd (0001981662) (Issuer)
- SECSEC Form 6-K filed by NewGenIvf Group Limited6-K - NewGenIvf Group Ltd (0001981662) (Filer)
- PRNewGenIVF Completes Exchange of Convertible Notes with Institutional InvestorBANGKOK, Aug. 17, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced that it has completed an exchange agreement with a certain institutional investor ("Investor") pursuant to which existing convertible notes held by the Investor were exchanged for a new senior convertible note on amended terms. The exchange closed on August 14, 2026. The restructuring eliminates the prior mandatory requirement that a significant percentage of proceeds from new capital raises be applied to prepay the notes under the Repurchase and Forbearance Agreement dated June 16, 2026, which was disclosed in the C
- SECSEC Form 6-K filed by NewGenIvf Group Limited6-K - NewGenIvf Group Ltd (0001981662) (Filer)
- SECSEC Form 6-K filed by NewGenIvf Group Limited6-K - NewGenIvf Group Ltd (0001981662) (Filer)
NIVF FAQ
4 questionsWhere does NIVF stock trade?
NewGenIvf Group Limited (NIVF) is listed on NASDAQ.What sector and industry is NIVF in?
NewGenIvf Group Limited operates in the Health Care sector, Misc Health and Biotechnology Services industry.What companies are similar to NIVF?
Notable peers in the same industry include FMS (Fresenius Medical Care AG), DVA (DaVita Inc.), SHC (Sotera Health Company), PGNY (Progyny Inc.), AGL (agilon health inc.). Compare NIVF side-by-side with any of them on Quantisnow.How can I track NIVF on Quantisnow?
Quantisnow aggregates NewGenIvf Group Limited's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NIVF to receive live email and push alerts on every new disclosure.